Search for a report

GLOBAL COUGH SYRUP MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • GLOBAL COUGH SYRUP MARKET FORECAST 2021-2028

GLOBAL COUGH SYRUP MARKET FORECAST 2021-2028

The global cough syrup market is projected to reach $7.21 billion by 2028, growing at a CAGR of 2.87% during the forecasted period. The base year considered for the studied market is 2020, and the estimated period is between 2021 and 2028. The market study has also analyzed the impact of COVID-19 on the global cough syrup market qualitatively as well as quantitatively.

GLOBAL COUGH SYRUP MARKET FORECAST 2021-2028

Global Cough Syrup Market by Product Type (Cough Suppressants/antitussives, Combination Medications, Expectorants) Market by Age Group (Adult, Pediatric) Market by Distribution Channels (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy) by Geography.

Request free sample

The global cough syrup market is projected to reach $7.21 billion by 2028, growing at a CAGR of 2.87% during the forecasted period. The base year considered for the studied market is 2020, and the estimated period is between 2021 and 2028. The market study has also analyzed the impact of COVID-19 on the global cough syrup market qualitatively as well as quantitatively. cough-syrup-market

To learn more about this report, request a free sample copy

Key enablers fueling the global cough syrup market growth:

  • Increase in chronic respiratory diseases
    • The amount of outdoor and interior air pollution caused by industrial and motor vehicle emissions is rising at an accelerated rate. This is mainly accredited to the rapid urbanization and increased energy consumption around the world.
    • As a result, the prevalence of respiratory symptoms such as coughing, wheezing, and impaired pulmonary function has increased significantly.
    • Respiratory diseases impose an immense worldwide health burden. For instance, chronic obstructive pulmonary disease (COPD) affects around 65 million people globally, with 3 million people dying each year. As a result, it is the third leading cause of death, according to the World Health Organization (WHO).
    • Asthma impacts approximately 334 million people worldwide. It is also the most common chronic childhood disease, affecting 14% of all children.
    • Hence, the surging number of patients suffering from respiratory diseases bolsters the demand for cough syrup products.
  • Rising geriatric population

Key growth restraining factors:

  • Overdose risks associated with cough syrup
    • According to industry estimates, around 95 million units of over-the-counter medicines are purchased each year for pediatric usage. However, improper administration can have life-threatening consequences.
    • In addition, numerous over-the-counter cough syrups constitute other active chemicals that may have serious health implications if taken incorrectly.
    • The number of teenagers who consume cough syrup is also on the rise. Dextromethorphan’s popularity among drug addicts rapidly elevates every day due to its easy availability, euphoric high, and psychedelic effects at higher dosages.
    • Dysphoria, lethargy, and sleeplessness are some of the long-term consequences of cough syrup. Besides, an overdose can also cause hypertension and seizures, as well.
  • Government regulations and restrictions

The report on the global cough syrup market includes segmentation analysis on the basis of product type, age group, and distribution channels.

Market by Product Type:

  • Combination Medications
    • Combination medications is anticipated to be the fastest-growing product in the market, progressing with a CAGR of 3.20%.
    • Expectorants, cough suppressants, and other active components are combined in combination medicines.
    • Antihistamines, pain relievers, and decongestants are some of the medications that can be used to treat several symptoms at once.
    • Pfizer Inc, Cipla Limited, Glenmark Pharmaceuticals Ltd, AstraZeneca PLC, etc., provide combination cough syrups. For example, Pfizer Inc offers Corex DX Syrup, a combination medicine used for treating dry cough.
  • Cough Suppressants/Antitussives
  • Expectorants

Geographically, the global cough syrup market has been segmented on the basis of four major regions, which includes:

  • North America: The United States and Canada
  • Europe: The United Kingdom, Russia, Belgium, Poland, Germany, France, Italy, and Rest of Europe
  • Asia-Pacific: China, Indonesia, Thailand, Vietnam, Japan, India, South Korea, Australia & New Zealand, and Rest of Asia-Pacific
    • Asia-Pacific is anticipated to be the largest regional market, harboring a revenue share of 30% in 2020.
    • Asia–Pacific has a varied population whose respiratory health is impacted by numerous social, economic, and environmental variables. Despite the diversity, cigarette smoking, illness, and air pollution are the most common causes of respiratory morbidity and mortality. Smoking-related disorders, respiratory viruses such as influenza and tuberculosis (TB), air pollution, and occupational lung diseases are among the leading respiratory health concerns in Asia–Pacific.
    • On account of the growing elderly population, people in countries such as Japan, Thailand, and South Korea are at risk of respiratory diseases. Moreover, the increased air pollution also leads to lung conditions such as tuberculosis, asthma, obstructive lung diseases, and others. Therefore, these factors play a vital role in fueling the region’s market growth.
  • Rest of World: Latin America, the Middle East & Africa

Major players in the global cough syrup market:

  • Johnson & Johnson
  • GlaxoSmithKline PLC
  • Proctor & Gamble Co
  • Pfizer Inc
  • Sanofi SA
  • Novartis International AG

Key strategies adopted by some of these companies:

In October 2020, GlaxoSmithKline PLC introduced Robitussin Naturals, the brand’s first-ever range of drug-free cough relievers. In January 2021, Sanofi SA agreed to acquire Kymab Ltd for $1.45 billion, in order to bolster its pipeline with experimental medicines for inflammation diseases as well as cancer.

Key trends of the global cough syrup market:

  • Several active pharmaceutical elements that taste bitter or irritate the tongue and throat are unpleasant to both children and many adults. Thus, cough syrup products with innovative tastes such as mango, ginger, honey, strawberry, raspberry, and vanilla are being offered as a unique answer to these complexities.
  • The use of herbal cough syrups has increased in recent years as an alternative to traditional cough syrups. Herbal cough syrups observe increased demand in numerous countries for primary health care since they are less expensive, have better compatibility with the human body, and result in minimal side effects.
  • Diabetes is becoming more common in low- and middle-income nations than in high-income countries. Diabetes patients are more likely to become infected with the cold or flu virus than non-diabetics due to their weakened immune systems. Hence, several companies offer sugar-free cough syrups. For instance, Wockhardt Hospitals is a healthcare company that offers Zedex Plus Cough Syrup, a sugar-free cough syrup used for treating dry cough.

 

Frequently Asked Questions (FAQs):

  • What are the ingredients of homeopathic cough syrups?

A: The ingredients used in the homeopathic cough syrups are allium cepa, Hepar sulphuris, natrum muriaticum, phosphorous, pulsatilla, sulfur, and Hydrastis, among others.

  • What are the newly introduced flavors under pediatric cough syrups?

A: Watermelon, grape, and bubblegum are the newly introduced flavors under pediatric cough syrups.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • RISING GERIATRIC POPULATION
      • INCREASE IN CHRONIC RESPIRATORY DISEASES
    • KEY RESTRAINTS
      • OVERDOSE RISKS ASSOCIATED WITH COUGH SYRUP
      • GOVERNMENT REGULATIONS AND RESTRICTIONS
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON COUGH SYRUP MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. MARKET BY PRODUCT TYPE
    • COUGH SUPPRESSANTS/ANTITUSSIVES
    • COMBINATION MEDICATIONS
    • EXPECTORANTS
  3. MARKET BY AGE GROUP
    • ADULT
    • PEDIATRIC
  4. MARKET BY DISTRIBUTION CHANNELS
    • RETAIL PHARMACY
    • HOSPITAL PHARMACY
    • ONLINE PHARMACY
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY DRIVERS
      • KEY CHALLENGES
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PARTNERSHIPS & AGREEMENTS
    • COMPANY PROFILES
      • ABBOTT LABORATORIES
      • ACELLA PHARMACEUTICALS LLC
      • ASTRAZENECA PLC
      • CIPLA LIMITED
      • DABUR INDIA LTD
      • GLAXOSMITHKLINE PLC
      • GLENMARK PHARMACEUTICAL LIMITED
      • JOHNSON & JOHNSON
      • MERCK KGAA
      • NOVARTIS INTERNATIONAL AG
      • PFIZER INC
      • PROCTOR & GAMBLE CO (P&G)
      • RECKITT BENCKISER GROUP PLC
      • SANOFI SA
      • THE HIMALAYA DRUG COMPANY

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – COUGH SYRUP

TABLE 2: THE COUNTRIES WITH THE LARGEST PERCENTAGE OF TOTAL POPULATION OVER 65 YEARS, IN 2020

TABLE 3: GLOBAL COUGH SYRUP MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 4: GLOBAL COUGH SYRUP MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 5: GLOBAL COUGH SUPPRESSANTS/ANTITUSSIVES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 6: GLOBAL COUGH SUPPRESSANTS/ANTITUSSIVES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 7: GLOBAL COMBINATION MEDICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 8: GLOBAL COMBINATION MEDICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 9: GLOBAL EXPECTORANTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 10: GLOBAL EXPECTORANTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 11: GLOBAL COUGH SYRUP MARKET, BY AGE GROUP, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 12: GLOBAL COUGH SYRUP MARKET, BY AGE GROUP, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 13: GLOBAL ADULT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 14: GLOBAL ADULT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 15: GLOBAL PEDIATRIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 16: GLOBAL PEDIATRIC MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 17: GLOBAL COUGH SYRUP MARKET, BY DISTRIBUTION CHANNELS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 18: GLOBAL COUGH SYRUP MARKET, BY DISTRIBUTION CHANNELS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 19: GLOBAL RETAIL PHARMACY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 20: GLOBAL RETAIL PHARMACY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 21: GLOBAL HOSPITAL PHARMACY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION

TABLE 22: GLOBAL HOSPITAL PHARMACY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 23: GLOBAL ONLINE PHARMACY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 24: GLOBAL ONLINE PHARMACY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 25: GLOBAL COUGH SYRUP MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 26: GLOBAL COUGH SYRUP MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 27: NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 28: NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 29: KEY PLAYERS IN NORTH AMERICA COUGH SYRUP MARKET

TABLE 30: EUROPE COUGH SYRUP MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 31: EUROPE COUGH SYRUP MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 32: KEY PLAYERS IN EUROPE COUGH SYRUP MARKET

TABLE 33: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 34: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 35: KEY PLAYERS IN ASIA-PACIFIC COUGH SYRUP MARKET

TABLE 36: REST OF THE WORLD COUGH SYRUP MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 37: REST OF THE WORLD COUGH SYRUP MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 38: KEY PLAYERS IN REST OF THE WORLD COUGH SYRUP MARKET

TABLE 39: LIST OF MERGERS & ACQUISITIONS

TABLE 40: LIST OF PARTNERSHIPS & AGREEMENTS

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: GLOBAL COUGH SYRUP MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2020

FIGURE 6: GLOBAL COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS/ANTITUSSIVES, 2021-2028 (IN $ MILLION)

FIGURE 7: GLOBAL COUGH SYRUP MARKET, BY COMBINATION MEDICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL COUGH SYRUP MARKET, BY EXPECTORANTS, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL COUGH SYRUP MARKET, GROWTH POTENTIAL, BY AGE GROUP, IN 2020

FIGURE 10: GLOBAL COUGH SYRUP MARKET, BY ADULT, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL COUGH SYRUP MARKET, BY PEDIATRIC, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL COUGH SYRUP MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNELS, IN 2020

FIGURE 13: GLOBAL COUGH SYRUP MARKET, BY RETAIL PHARMACY, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL COUGH SYRUP MARKET, BY HOSPITAL PHARMACY, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL COUGH SYRUP MARKET, BY ONLINE PHARMACY, 2021-2028 (IN $ MILLION)

FIGURE 16: NORTH AMERICA COUGH SYRUP MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 17: UNITED STATES COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 18: CANADA COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 19: EUROPE COUGH SYRUP MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 20: UNITED KINGDOM COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 21: GERMANY COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 22: FRANCE COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 23: ITALY COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 24: RUSSIA COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 25: BELGIUM COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 26: POLAND COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 27: REST OF EUROPE COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 28: ASIA-PACIFIC COUGH SYRUP MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 29: CHINA COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: JAPAN COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: INDIA COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: SOUTH KOREA COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 33: INDONESIA COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: THAILAND COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 35: VIETNAM COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 36: AUSTRALIA & NEW ZEALAND COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 37: REST OF ASIA-PACIFIC COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 38: REST OF THE WORLD COUGH SYRUP MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 39: LATIN AMERICA COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

FIGURE 40: MIDDLE EAST & AFRICA COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

MARKET BY TYPE

  • TYPE A
  • TYPE B

MARKET BY APPLICATION

  • COSMETIC APPLICATIONS
    • GLABELLAR LINES
    • LATERAL CANTHAL LINES (CROW’S FEET)
    • FOREHEAD LINES
    • OTHER COSMETIC APPLICATIONS
  • NON-COSMETIC APPLICATIONS
    • DYSTONIA
    • CHRONIC MIGRAINE
    • OPHTHALMOLOGIC DISORDERS
    • OTHER NON-COSMETIC APPLICATIONS

MARKET BY END-USER

  • HOSPITALS
  • CLINICS AND OTHERS

GEOGRAPHICAL ANALYSIS

  • NORTH AMERICA
    • KEY GROWTH ENABLERS
    • KEY CHALLENGES
    • KEY PLAYERS
    • COUNTRY ANALYSIS
      • UNITED STATES
      • CANADA
  • EUROPE
    • KEY GROWTH ENABLERS
    • KEY CHALLENGES
    • KEY PLAYERS
    • COUNTRY ANALYSIS
      • UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
  • ASIA-PACIFIC
    • KEY GROWTH ENABLERS
    • KEY CHALLENGES
    • KEY PLAYERS
    • COUNTRY ANALYSIS
      • CHINA
      • JAPAN
      • INDIA
      • SOUTH KOREA
      • SINGAPORE
      • THAILAND
      • VIETNAM
      • AUSTRALIA & NEW ZEALAND
      • REST OF ASIA-PACIFIC
  • REST OF WORLD
    • KEY GROWTH ENABLERS
    • KEY CHALLENGES
    • KEY PLAYERS
    • REGIONAL ANALYSIS
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA

 

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Choose License Type

    Buy Now